Forget JEPI, Goldman’s Income Beat Has Surged Since Launch
A new income-focused ETF challenger has pushed past JEPI by roughly 42 percentage points since its October 2023 debut...
Index level declines can reflect profit-taking, macro shocks, or sector rotations. This intro covers common indicators to read with context.
23,215 articlesA new income-focused ETF challenger has pushed past JEPI by roughly 42 percentage points since its October 2023 debut...
Three international dividend ETFs are delivering notably higher yields than SCHD in mid-2026, driven by cheaper overs...
SpaceX's public debut created big waves, but a recent pullback has many investors asking if it’s time to buy. This ar...
The Invesco RAFI Developed Markets ex-US ETF (PXF) has risen about 85.43% in five years while continuing to pay stead...
SpaceX’s public debut has revived a long-standing fight over dual-class voting. Investors and watchdogs are weighing ...
If you’re wondering what the next year holds for stocks, this guide stays grounded. It blends data, real-world exampl...
A Jordan base attack left two U.S. service members dead and one missing as tensions flare with Iran. The fallout hits...
The SPDR S&P Retail ETF has posted double-digit gains over the last year, yet leaders emerge among value-focused reta...
Warner Bros. Discovery has formally labeled Paramount Skydance’s all-cash bid superior to Netflix’s, kicking off a sh...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
International equities are outperforming U.S. stocks in early 2026, with VXUS leading the charge. The shift has many ...
NVIDIA has powered the AI rally, and investors are asking if the story can continue. Here's a practical guide on what...